Dysmenorrhea: risk factors in women with endometriosis
- PMID: 19072504
- DOI: 10.2217/17455057.4.4.399
Dysmenorrhea: risk factors in women with endometriosis
Abstract
Although it is generally accepted that endometriosis is responsible for dysmenorrhea, as well as other symptoms such as infertility, the precise relationship between the severity of dysmenorrhea and various characteristics of disease, such as stage and the type or site of endometriotic lesions, has been elusive and often a matter of heated debate, owing largely to conflicting reports. Here we review factors that are reported to be associated with dysmenorrhea in endometriosis. We also demonstrate, through a real example, that different statistical models employed in data analyses may yield somewhat different sets of risk factors, and the difference may not be always resolved within the same data set. In addition, we make the point that despite the best-fitting models, there may still be a sizable portion of variation in the severity of dysmenorrhea that can not be explained completely by the identified risk factors, suggesting that factors other than those of surgical findings or patient characteristics may also be responsible for dysmenorrhea severity. We review some possible factors that may also be responsible for the risk and severity of dysmenorrhea. Finally, we expose areas in need of further research.
Similar articles
-
Risk factors for dysmenorrhea and its severity in women with ovarian endometriomas.Gynecol Obstet Invest. 2008;66(3):169-77. doi: 10.1159/000140513. Epub 2008 Jun 19. Gynecol Obstet Invest. 2008. PMID: 18562797
-
[Relationship between pain symptoms and clinico-pathological features of pelvic endometriosis].Zhonghua Fu Chan Ke Za Zhi. 2007 Mar;42(3):165-8. Zhonghua Fu Chan Ke Za Zhi. 2007. PMID: 17537300 Chinese.
-
[Painful symptoms of pelvic endometriosis].Zhonghua Fu Chan Ke Za Zhi. 1995 Jan;30(1):30-3. Zhonghua Fu Chan Ke Za Zhi. 1995. PMID: 7750405 Chinese.
-
Problems with the diagnosis of endometriosis.Womens Health (Lond). 2015 Aug;11(5):597-601. doi: 10.2217/whe.15.44. Epub 2015 Sep 21. Womens Health (Lond). 2015. PMID: 26389666 Review.
-
[Management of endometriosis: clinical and biological assessment].J Gynecol Obstet Biol Reprod (Paris). 2007 Apr;36(2):119-28. doi: 10.1016/j.jgyn.2006.12.020. Epub 2007 Feb 2. J Gynecol Obstet Biol Reprod (Paris). 2007. PMID: 17276015 Review. French.
Cited by
-
Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis.Reprod Sci. 2013 Dec;20(12):1478-91. doi: 10.1177/1933719113488455. Epub 2013 May 23. Reprod Sci. 2013. PMID: 23703534 Free PMC article.
-
Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis.Sci Rep. 2019 Jun 25;9(1):9272. doi: 10.1038/s41598-019-45785-w. Sci Rep. 2019. PMID: 31239500 Free PMC article.
-
Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence.Reprod Biol Endocrinol. 2016 Oct 10;14(1):66. doi: 10.1186/s12958-016-0198-1. Reprod Biol Endocrinol. 2016. PMID: 27724926 Free PMC article.
-
A call for more transparency of registered clinical trials on endometriosis.Hum Reprod. 2009 Jun;24(6):1247-54. doi: 10.1093/humrep/dep045. Epub 2009 Mar 4. Hum Reprod. 2009. PMID: 19264712 Free PMC article. Review.
-
Pathophysiology of Endometriosis: Insights from Immunohistochemical Analysis of Ectopic and Eutopic Tissues.Int J Mol Sci. 2025 Jun 22;26(13):5998. doi: 10.3390/ijms26135998. Int J Mol Sci. 2025. PMID: 40649777 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical